about
Evaluation of in vivo labelled dendritic cell migration in cancer patientsT-cell activation promotes tumorigenesis in inflammation-associated cancer.Lung and splenic B cells facilitate diverse effects on in vitro measures of antitumor immune responsesUse of tumour-responsive T cells as cancer treatment.Dendritic cell-based immunotherapy for the treatment of hematological malignancies.Dendritic cell vaccination and immunostimulation in advanced melanoma.Evaluation of natural killer cell (CD57) as a prognostic marker in oral squamous cell carcinoma: An immunohistochemistry study.Dendritic cell dysfunction in cancer: a mechanism for immunosuppression.Microarray analysis reveals potential mechanisms of BRMS1-mediated metastasis suppressionImproved antitumour immunity in murine neuroblastoma using a combination of IL-2 and IL-12.Adjuvant treatment of melanomaPotential functional role of plasmacytoid dendritic cells in cancer immunity.Genetically engineered Tobacco mosaic virus as nanoparticle vaccines.The influence of different culture microenvironments on the generation of dendritic cells from non-small-cell lung cancer patients.Nano-scaled particles of titanium dioxide convert benign mouse fibrosarcoma cells into aggressive tumor cells.Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model.An in vitro model demonstrates the potential of neoplastic human germ cells to influence the tumour microenvironment.Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer.Self-Assembly Protein Nanogels for Safer Cancer Immunotherapy.Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma.Influence of serum and soluble CD25 (sCD25) on regulatory and effector T-cell function in hepatocellular carcinoma.Activation of tumor-associated macrophages by thymosin alpha 1.Cyclin E overexpression enhances cytokine-mediated apoptosis in MCF7 breast cancer cells.Immunomodulatory and antitumor actions of medicinal plant Tinospora cordifolia are mediated through activation of tumor-associated macrophages.
P2860
Q24799742-28FDA804-BB58-4B89-AA9F-C1F90EC8B6F3Q33590130-083B94A5-1DEB-45EC-830C-859DC70C0C8AQ34111836-74D2D7E6-C784-44AA-9023-204235640C49Q34285656-EDB7F1DC-9357-4A8C-919B-D809BA7EF015Q35127001-29EB5365-DC6A-4BBB-B5A1-DE87C9AAD2E0Q35623395-D881A926-3550-406D-B948-5E47E5A51E36Q36124865-C2450F55-E917-4725-A9AA-A8A7111A6FFDQ36262281-7AD2E2D7-A6A2-4432-8A3E-940CACC6F481Q36407507-30B82A75-DBE1-479A-B3F3-CA495FF0D67FQ36648910-CC6E0F85-3CDB-4D85-9B04-132B9311610FQ36656595-3252F42E-50B1-4A96-A1DF-D10FF99073E5Q36764252-20436EAA-04F4-4CB3-9E95-A671B35E298BQ37077649-877D6BA7-D554-4DB1-9474-41EF4E90E4DFQ37397746-7CEBB732-8489-4208-A3FD-C5A6A3A45A8BQ37413720-1D2074D1-EA92-4E0E-89DD-2B8E1872AD58Q37706248-9914E223-27CB-4283-9593-03D6E12DB613Q38702278-D23E48F3-DEB0-49C1-973A-50C7B778F01DQ39764766-67045070-8D58-4112-BA2E-12F5B961E701Q41158336-168551A3-3117-4AF9-8B4A-72CD29439FFDQ41543718-2CA93E2C-8395-47D4-B8D9-47AA665DE0F9Q42112406-4235DBC5-D35D-487D-B87C-45F5A8F2F71FQ44786508-18E241D6-2AA4-4CE2-BD04-57CF68793F95Q46090981-08E23DA9-A984-47E6-A016-31DD3F9B3567Q47707528-FB395486-9365-430D-BB03-0332FAE63D95
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Immunologic mechanisms of antitumor activity.
@ast
Immunologic mechanisms of antitumor activity.
@en
Immunologic mechanisms of antitumor activity.
@nl
type
label
Immunologic mechanisms of antitumor activity.
@ast
Immunologic mechanisms of antitumor activity.
@en
Immunologic mechanisms of antitumor activity.
@nl
prefLabel
Immunologic mechanisms of antitumor activity.
@ast
Immunologic mechanisms of antitumor activity.
@en
Immunologic mechanisms of antitumor activity.
@nl
P356
P1433
P1476
Immunologic mechanisms of antitumor activity.
@en
P2093
Francine M Foss
P356
10.1053/SONC.2002.33076
P433
P577
2002-06-01T00:00:00Z